Summary: Open Society Foundations examines bureaucratic barriers surrounding MDMA, LSD, and cannabis research. The article covers an upcoming study researching MDMA-assisted psychotherapy as a potential treatment for alcoholism. “By labeling MDMA, among other substances, as Schedule 1, governments have created a huge barrier to scientific research, depriving the world of possible breakthroughs in health and knowledge,” explains Naomi Burke-Shyne of Open Society Foundations. “National governments could reclassify substances such as MDMA, cannabis, and LSD to less restrictive schedules, which would put them under more feasible regulatory control and open up options for scientific research—while still being in compliance with the abovementioned conventions.”
